You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR HSK3486

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for HSK3486

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT03674008 ↗	A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd	Phase 3	This is a Phase III, randomized, double-blind, propofol-controlled, parallel-design, multi-center study to evaluate the efficacy and safety of HSK3486 for sedation or anesthesia in patients undergoing colonoscopy and gastroscopy. The study will enroll approximately 280 adults. The maximum study duration is anticipated to be up to nine months.
NCT03674008 ↗	A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd.	Phase 3	This is a Phase III, randomized, double-blind, propofol-controlled, parallel-design, multi-center study to evaluate the efficacy and safety of HSK3486 for sedation or anesthesia in patients undergoing colonoscopy and gastroscopy. The study will enroll approximately 280 adults. The maximum study duration is anticipated to be up to nine months.
NCT03709056 ↗	A Study Evaluating the Efficacy and Safety of HSK3486	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd	Phase 2	A double-blind, randomized, active controlled, multi-center, parallel group study comparing HSK3486 with Propofol, in patients undergoing a colonoscopy.
NCT03709056 ↗	A Study Evaluating the Efficacy and Safety of HSK3486	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd.	Phase 2	A double-blind, randomized, active controlled, multi-center, parallel group study comparing HSK3486 with Propofol, in patients undergoing a colonoscopy.
NCT03745625 ↗	A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd	Phase 1	This is a Phase I, single-center, open-label, randomized,two-way crossover, propofol-controlled, two-stage study evaluating the safety and pharmacokinetics/pharmacodynamics of IV maintenance dose after an initial dose and IV single loade dose plus maintenance dose of HSK3486 emulsion for injection in healthy subjects.
NCT03745625 ↗	A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486	Completed	Sichuan Haisco Pharmaceutical Group Co., Ltd.	Phase 1	This is a Phase I, single-center, open-label, randomized,two-way crossover, propofol-controlled, two-stage study evaluating the safety and pharmacokinetics/pharmacodynamics of IV maintenance dose after an initial dose and IV single loade dose plus maintenance dose of HSK3486 emulsion for injection in healthy subjects.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for HSK3486

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Sedation	11
Anesthesia	10
General Anesthesia	3
Sedation in Intensive Care	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Renal Insufficiency, Chronic	1
Renal Insufficiency	1
Liver Neoplasms	1
Postoperative Complications	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for HSK3486

Trials by Country

Map
Table

Trials by Country
Location	Trials
China	18
United States	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State
Location	Trials
Utah	2
Texas	1
Ohio	1
North Carolina	1
New York	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for HSK3486

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
Phase 3	8
Phase 2	5
Phase 1	14
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Completed	19
Not yet recruiting	6
Recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for HSK3486

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Sichuan Haisco Pharmaceutical Group Co., Ltd.	21
Sichuan Haisco Pharmaceutical Group Co., Ltd	20
Haisco-USA Pharmaceuticals, Inc.	4
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Industry	48
Other	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.